$PTCT
PTC Therapeutics, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$65.37
▼-3.87%-$2.63
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePTC Therapeutics, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is PTCT down today? It is at $65.37 (-3.87%), and our scanner flagged it 43 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PTCT spikes, and full due diligence on PTCT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PTCT 43 times in the last 30 days. Create a free account to track $PTCT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PTCT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PTCT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Schmertzler Michael Director | Sold (automatic/other) | -10K 0.01% of company | sold 0.8% | 1.32M | $673K at $67.34 | Sep 10, 26 |
Schmertzler Michael Director | Sold (automatic/other) | -10K 0.01% of company | sold 0.7% | 1.33M | $678K at $67.79 | Sep 9, 26 |
Schmertzler Michael Director | Sold (automatic/other) | -13K 0.01% of company | sold 0.9% | 1.34M | $894K at $71.55 | Aug 27, 26 |
Schmertzler Michael Director | Sold (automatic/other) | -13K 0.01% of company | sold 0.9% | 1.35M | $909K at $72.74 | Aug 26, 26 |
Schmertzler Michael Director | Sold (automatic/other) | -13K 0.01% of company | sold 0.9% | 1.36M | $885K at $70.78 | Aug 20, 26 |
Schmertzler Michael Director | Sold (automatic/other) | -13K 0.01% of company | sold 0.9% | 1.37M | $911K at $72.86 | Aug 19, 26 |
Boulding Mark Elliott Officer | Sold (automatic/other) | -3K | sold 2.6% | 105K | $204K at $72.39 | Aug 17, 26 |
Boulding Mark Elliott Officer | Other | 3K | added 2.7% | 108K | $72K at $25.69 | Aug 17, 26 |
Klein Matthew B. Officer | Sold (automatic/other) | -10K 0.01% of company | sold 2.6% | 384K | $706K at $68.57 | Aug 4, 26 |
Sollie-Zetlmayer Hege Elisabeth Director | Acquired (grant/award) | +6K | added 13% | 53K | n/a | Jul 28, 26 |
Gravier Pierre Officer | Sold (automatic/other) | -3K | sold 4.0% | 84K | $281K at $80.35 | Jul 14, 26 |
Almstead Neil Gregory Officer | Sold (automatic/other) | -2K | sold 3.9% | 60K | $222K at $90.25 | Jul 9, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on PTCT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PTCT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
PTCT last traded at $65.37, down 3.87% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
PTC Therapeutics, Inc. (PTCT) is next expected to report earnings on Tuesday, November 3, 2026, about 44 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PTCT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PTCT 43 times in the last 30 days.
PTCT (PTC Therapeutics, Inc.) trades on XNAS, with a market cap of about $5.46B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PTCT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PTCT discussion
Sign in to ask a question or join the discussion.